Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)

Triple Negative Breast Cancer (TNBC) is defined by the lack of ERα, PR expression and HER2 overexpression and is the breast cancer subtype with the poorest clinical outcomes. Our aim was to identify genes driving TNBC proliferation and/or survival which could represent novel therapeutic targets. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Orr, Katy, Buckley, Niamh E., Haddock, Paula, James, Colin, Parent, Jean-Luc, McQuaid, Stephen, Mullan, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342429/
https://www.ncbi.nlm.nih.gov/pubmed/27487152
http://dx.doi.org/10.18632/oncotarget.10969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342429/
https://www.ncbi.nlm.nih.gov/pubmed/27487152
http://dx.doi.org/10.18632/oncotarget.10969

Ejemplares similares